Genmab A/S
OTC:GNMSF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genmab A/S
OTC:GNMSF
|
DK |
|
H
|
Heritage Distilling Holding Company Inc
NASDAQ:CASK
|
US |
|
Nippon Sanso Holdings Corp
F:NPX
|
JP |
|
W
|
WHA Industrial Leasehold Real Estate Investment Trust
SET:WHAIR
|
TH |
Wall St Price Targets
GNMSF Price Targets Summary
Genmab A/S
According to Wall Street analysts, the average 1-year price target for GNMSF is 329.96 USD with a low forecast of 190.45 USD and a high forecast of 456.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GNMSF's stock price target?
Price Target
329.96
USD
According to Wall Street analysts, the average 1-year price target for GNMSF is 329.96 USD with a low forecast of 190.45 USD and a high forecast of 456.9 USD.
What is the Revenue forecast for Genmab A/S?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 34%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Genmab A/S?
Projected CAGR
7%
The compound annual growth rate for Gross Profit over the next 8 years is 7%.
What is the Operating Income forecast for Genmab A/S?
Projected CAGR
10%
The compound annual growth rate for Operating Income over the next 8 years is 10%.
What is the Pre-Tax Income forecast for Genmab A/S?
Projected CAGR
16%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 16%.
What is the Net Income forecast for Genmab A/S?
Projected CAGR
12%
The compound annual growth rate for Net Income over the next 8 years is 12%.
